BPG is committed to discovery and dissemination of knowledge
Articles in Press
5/8/2025 8:41:18 AM | Browse: 59 | Download: 0
Category |
Radiology, Nuclear Medicine & Medical Imaging |
Manuscript Type |
Editorial |
Article Title |
Harnessing artificial intelligence to address immune response heterogeneity in low-dose radiation therapy
|
Manuscript Source |
Invited Manuscript |
All Author List |
Jing-Qi Zeng, Yi-Wei Gao and Xiao-Bin Jia |
Funding Agency and Grant Number |
|
Corresponding Author |
Jing-Qi Zeng, Academic Fellow, Postdoc, School of Traditional Chinese Pharmacy, China Pharmaceutical University, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, PR China. Electronic address: zjingqi@163.com, Nanjing 211198, Jiangsu Province, China. zjingqi@163.com |
Key Words |
Low-dose radiation; Immune response; Heterogeneity; Artificial intelligence; Precision medicine; Immunotherapy; Radiomics |
Core Tip |
Artificial intelligence (AI) is revolutionizing low-dose radiation (LDR) therapy by addressing immune response heterogeneity in patients with cancer. By integrating multidimensional datasets such as immunomics, radiomics, and clinical profiles, AI employs advanced machine learning to decode complex immune patterns and predict individualized therapeutic outcomes. This enables tailored treatment strategies that enhance antitumor efficacy while minimizing side effects. Thus, AI paves the way for precision oncology and by enabling customized treatments for each patient’s unique biological signature. |
Citation |
Zeng J, Gao Y, Jia X. Harnessing artificial intelligence to address immune response heterogeneity in low-dose radiation therapy. World J Radiol 2025; In press |
 |
Received |
|
2025-04-03 03:24 |
 |
Peer-Review Started |
|
2025-04-03 03:24 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2025-04-11 09:55 |
 |
Revised |
|
2025-04-12 02:56 |
 |
Second Decision |
|
2025-05-08 02:48 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2025-05-08 08:41 |
 |
Articles in Press |
|
2025-05-08 08:41 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
2025-05-13 20:28 |
 |
Typeset the Manuscript |
|
|
ISSN |
1949-8470 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345